{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:29:13Z","timestamp":1792726153268,"version":"4.5.0"},"reference-count":40,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9102-17","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T18:12:21Z","timestamp":1509473541000},"page":"429-435","source":"Crossref","is-referenced-by-count":27,"title":["&lt;i&gt;Mycobacterium bovis&lt;\/i&gt;-induced Aneurysm after Intravesical Bacillus Calmette-Gu\u00e9rin Therapy: A Case Study and Literature Review"],"prefix":"10.2169","volume":"57","author":[{"given":"Yoshitsugu","family":"Higashi","sequence":"first","affiliation":[{"name":"Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Kidani","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Matumoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koyomi","family":"Kawago","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Isobe","sequence":"additional","affiliation":[{"name":"Department of Bacteology, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kanatani","sequence":"additional","affiliation":[{"name":"Department of Bacteology, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Kawagishi","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Kurobe City Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippei","family":"Sakamaki","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Prescott S, Jackson AM, Hawkard SJ, Alecandroff AB, James K. Mechanisms of action of intravesical bacille Calmette-Gu\u00e9rin: local immune mechanisms. Clin Infect Dis 3: S91-S93, 2000."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bohle A, Brandau S. Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol 170: 964-969, 2003.","DOI":"10.1097\/01.ju.0000073852.24341.4a"},{"key":"3","unstructured":"3. Patard J, Moudouni S, Saint F, et al. Tumor progression and survival in patients with T1 G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years. Urology 58: 551-556, 2001."},{"key":"4","unstructured":"4. Matsuda T, Marugame T, Kamo K, Katanoba K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 42: 139-147, 2012."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lamm DL, van der Meijden PM, Morales A, et al. Incidence and treatment of complications of bacillus Calmette-Gu\u00e9rin intravesical therapy in superficial bladder cancer. J Urol 147: 596-600, 1992.","DOI":"10.1016\/S0022-5347(17)37316-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chikamatsu K, Aono A, Yamada H, et al. Comparative evaluation of three immunochromatographic identification tests for culture confirmation of <i>Mycobacterium tuberculosis<\/i> complex. BMC infect Dis 14: 54, 2014.","DOI":"10.1186\/1471-2334-14-54"},{"key":"7","unstructured":"7. Muller BT, Wegener OR, Grabitz K, Pillny M, Thomas L, Sandmann W. Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg 33: 106-113, 2001."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chan FY, Crawford ES, Coselli JS, Safi HJ, Williams TW Jr. <i>In situ<\/i> prosthetic graft replacement for mycotic aneurysm of the aorta. Ann Thorac Surg 47: 193-203, 1989.","DOI":"10.1016\/0003-4975(89)90268-3"},{"key":"9","unstructured":"9. Miller DV, Oderich GS, Aubry MC, Panneton JM, Edwards WD. Surgical pathology of infected aneurysms of the descending thoracic and abdominal aorta: clinicopathologic correlations in 29 cases (1976 to 1999). Hum Pathol 35: 1112-1120, 2004."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Scott C, Cavanaugh JS, Pratt R, Silk BJ, LoBue P, Moonan PK. Human tuberculosis caused by <i>Mycobacterium bovis<\/i> in the United States, 2006-2013. Clin Infect Dis 63: 594-601, 2016.","DOI":"10.1093\/cid\/ciw371"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Woods JM 4th, Schellack J, Stewart MT, Murray DR, Schwartzman SW. Mycotic abdominal aortic aneurysm induced by immunotherapy with bacille Calmette-Gu\u00e9rin vaccine for malignancy. J Vasc Surg 7: 808-810, 1988.","DOI":"10.1016\/0741-5214(88)90048-1"},{"key":"12","unstructured":"12. Bornet P, Pujade B, Lacaine F, et al. Tuberculous aneurysm of the femoral artery: a complication of bacille Calmette-Gu\u00e9rin vaccine immunotherapy--a case report. J Vasc Surg 10: 688-692, 1989."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Deresiewicz RL, Stone RM, Aster JC. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin. J Urol 144: 1331-1333, 1990.","DOI":"10.1016\/S0022-5347(17)39732-X"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Izes JK, Bihrle W, Thomas CB. Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin. J Urol 150: 1498-1500, 1993.","DOI":"10.1016\/S0022-5347(17)35824-X"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wolf YG, Wolf DG, Higginbottom PA, Dilley RB. Infection of a ruptured aortic aneurysm and an aortic graft with bacille Calmette-Gu\u00e9rin after intravesical administration for bladder cancer. J Vasc Surg 22: 80-84, 1995.","DOI":"10.1016\/S0741-5214(95)70092-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hellinger WC, Oldenburg WA, Alvarez S. Vascular and other serious infections with <i>Mycobacterium bovis<\/i> after bacillus of Calmette-Gu\u00e9rin therapy for bladder cancer. South Med J 88: 1212-1216, 1995.","DOI":"10.1097\/00007611-199512000-00005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rozenblit A, Wasserman E, Marin ML, Veith FJ, Cynamon J, Rozenblit G. Infected aortic aneurysm and vertebral osteomyelitis after intravesical bacillus Calmette-Gu\u00e9rin therapy. AJR Am J Roentgenol 167: 711-713, 1996.","DOI":"10.2214\/ajr.167.3.8751686"},{"key":"18","unstructured":"18. Damm O, Briheim G, Hagstrom T, Jonsson B, Skau T. Ruptured mycotic aneurysm of the abdominal aorta: a serious complication of intravesical instillation bacillus Calmette-Guerin therapy. J Urol 159: 984, 1998."},{"key":"19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiology.211.1.r99ap4081","volume":"211","author":"JM LaBerge","year":"1999","unstructured":"19. LaBerge JM, Kerlan RK Jr, Reilly LM, Chuter TA. Diagnosis please. Case 9: mycotic pseudoaneurysm of the abdominal aorta in association with mycobacterial psoas abscess--a complication of BCG therapy. Radiology 211: 81-85, 1999.","journal-title":"Radiology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-8419","issn-type":"print"},{"key":"20","unstructured":"20. Seelig MH, Oldenburg WA, Klingler PJ, Blute ML, Pairolero PC. Mycotic vascular infections of large arteries with <i>Mycobacterium bovis<\/i> after intravesical bacillus Calmette-Gu\u00e9rin therapy: case report. J Vasc Surg 29: 377-381, 1999."},{"key":"21","unstructured":"21. Farber A, Grigoryants V, Palac DM, Chapman T, Cronenwett JL, Powell RJ. Primary aortoduodenal fistula in a patient with a history of intravesical therapy for bladder cancer with bacillus Calmette-Gu\u00e9rin: review of primary aortoduodenal fistula without abdominal aortic aneurysm. J Vasc Surg 33: 868-873, 2001."},{"key":"22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000050539","volume":"68","author":"H Geldmacher","year":"2001","unstructured":"22. Geldmacher H, Taube C, Markert U, Kirsten DK. Nearly fatal complications of cervical lymphadenitis following BCG immunotherapy for superficial bladder cancer. Respiration 68: 420-421, 2001.","journal-title":"Respiration","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7931","issn-type":"print"},{"key":"23","unstructured":"23. Kamphuis JT, Buiting AG, Misere JF, van Berge Henegouwen DP, van Soolingen D, Rensma PL. BCG immunotherapy: be cautious of granulomas. Disseminated BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations Neth J Med 58: 71-75, 2001."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wada S, Watanabe Y, Shiono N, et al. Tuberculous abdominal aortic pseudoaneurysm penetrating the left psoas muscle after BCG therapy for bladder cancer. Cardiovasc Surg 11: 231-235, 2003.","DOI":"10.1016\/S0967-2109(03)00002-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Witjes JA, Vriesema JL, Brinkman K, Bootsma G, Barentsz JO. Mycotic aneurysm of the popliteal artery as a complication of intravesical BCG therapy for superficial bladder cancer. Case report and literature review. Urol Int 71: 430-432, 2003.","DOI":"10.1159\/000074100"},{"key":"26","unstructured":"26. Dahl T, Lange C, \u00d8deg\u00e5rd A, Bergh K, Osen SS, Myhre HO. Ruptured abdominal aortic aneurysm secondary to tuberculous spondylitis. Int Angiol 24: 98-101, 2005."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Harding GE, Lawlor DK. Ruptured mycotic abdominal aneurysm secondary to <i>Mycobacterium bovis<\/i> after intravesical treatment with bacillus Calmette-Gu\u00e9rin. J Vasc Surg 46: 131-134, 2007.","DOI":"10.1016\/j.jvs.2007.01.054"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Safdar N, Abad CL, Kaul DR, Jarrard D, Saint S. Clinical problem-solving. An unintended consequence--a 79-year-old man with a 5-month history of fatigue and 20-Ib (9-kg) weight loss presented to his local physician. N Engl J Med 358: 1496-1501, 2008.","DOI":"10.1056\/NEJMcps0706711"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Costiniuk CT, Sharapov AA, Rose GW, et al. Mycobacterium bovis abdominal aortic and femoral artery aneurysms following intravesical bacillus Calmette-Gu\u00e9rin therapy for bladder cancer. Cardiovasc Pathol 19: e29-e32, 2010.","DOI":"10.1016\/j.carpath.2008.09.003"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Coscas R, Arlet JB, Belhomme D, Fabiani JN, Pouchot J. Multiple mycotic aneurysms due to <i>Mycobacterium bovis<\/i> after intravesical bacillus Calmette-Gu\u00e9rin therapy. J Vasc Surg 50: 1185-1190, 2009.","DOI":"10.1016\/j.jvs.2009.06.004"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Maundrell J, Fletcher S, Roberts P, Stein A, Lambie M. Mycotic aneurysm of the aorta as a complication of Bacillus Calmette-Gu\u00e9rin instillation. J R Coll Physicians Edinb 41: 114-116, 2011.","DOI":"10.4997\/JRCPE.2011.203"},{"key":"32","unstructured":"32. Orii K, Honda J, Hirai Y. Tuberculous abdominal aortic aneurysm after intravesical bacillus Calmette-Gu\u00e9rin therapy. Jpn J Vasc Surg 21: 803-808, 2012 (in Japanese, Abstract in English)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kioka Y, Tanabe A, Kuriyama M. A case report of mycotic aneurysm following intravasical bacillus Calmette-Gu\u00e9rin instillation therapy for bladder cancer. Jpn J Cardiovasc Surg 41: 312-315, 2012 (in Japanese, Abstract in English).","DOI":"10.4326\/jjcvs.41.312"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Asami F, Yamaguchi H, Nakao T, et al. A pseudoaneurysm of abdominal aorta-after intravasical bacillus Calmette-Gu\u00e9rin therapy. Jpn J Cardiovasc Surg 42: 197-199, 2013 (in Japanese, Abstract in English).","DOI":"10.4326\/jjcvs.42.197"},{"key":"35","unstructured":"35. Fujii K, Mizumoto T, Shomura Y, Fujinaga K, Sawada Y. A case of tuberculous multiple aortic aneurysm after intravesical bacillus Calmette-Gu\u00e9rin therapy. Jpn J Vasc Surg 24: 822-826, 2015 (in Japanese, Abstract in English)."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Nam EY, Na SH, Kim SY, et al. Infected aortic aneurysm caused by <i>Mycobacterium bovis<\/i> after intravesical Bacillus Calmette-Gu\u00e9rin treatment for bladder cancer. Infect Chemother 47: 256-260, 2015.","DOI":"10.3947\/ic.2015.47.4.256"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Lee WK, Mossop PJ, Little AF, et al. Infected (mycotic) aneurysms: spectrum of imaging appearances and management. Radiographics 28: 1853-1868, 2008.","DOI":"10.1148\/rg.287085054"},{"key":"38","unstructured":"38. Long R, Guzman R, Greenberg H, Safneck J, Hershfield E. Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience. Chest 115: 523-531, 1999."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Lamm DL, van der Maijden PM, Morales A, et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 147: 596-600, 1992.","DOI":"10.1016\/S0022-5347(17)37316-0"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ting AC, Cheng SW, Ho P, Poon JT. Endovascular repair for multiple Salmonella mycotic aneurysms of the thoracic aorta presenting with Cardiovocal syndrome. Eur J Cardiothorac Surg 26: 221-224, 2004.","DOI":"10.1016\/j.ejcts.2004.03.035"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/3\/57_9102-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T07:48:21Z","timestamp":1570261701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/3\/57_9102-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9102-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}